deaths (OS)

ovarian cancer (OC) ovarian cancer (OC)

versus Standard of Care (SoC)
niraparib vs. Standard of Care (SoC) 1 -
olaparib vs. Standard of Care (SoC) 5 safety concern-16%
rucaparib vs. Standard of Care (SoC) 2 safety concern+31%

mOC - L1 - all population metastatic/advanced OC (mOC) - 1st line (L1) mOC - L1 - all population

mOC - L1 - PDL1 positive metastatic/advanced OC (mOC) - 1st line (L1) mOC - L1 - PDL1 positive

metastatic/advanced OC (mOC) - 2nd line (L2) metastatic/advanced OC (mOC) - 2nd line (L2)

metastatic/advanced OC (mOC) - maintenance (M) metastatic/advanced OC (mOC) - maintenance (M)